Dr Martens’ six-month results for the FY26 period to late September on Thursday showed the execution of its new strategy on track with full-price DTC revenue rising 6%.

But there were still some negative figures with overall revenue on a reported basis dipping by 0.8% to £322 million. Yet it would have risen by 0.8% at constant currency rates (CCY) so overall, it's a reasonably good figure.

And the company said adjusted EBIT was £3.1 million (or £3.4 million CCY), up from a loss on the same basis of £3 million a year earlier.

Adjusted profit before tax was actually a loss of £9.4 million (or £9.2 million CCY), which again, was better than the deficit of £16.6 million in H1 of FY25.

Unadjusted profit before tax was a loss of £11 million (£12.3 million CCY), also narrower than the year a

See Full Page